Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? - Wikidata - awgldk - TriplyDB

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

http://www.wikidata.org/entity/Q53259076

about

Cerebrospinal fluid biomarkers of Alzheimer’s disease Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Biomarkers of Alzheimer's disease Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD Harmonized diagnostic criteria for Alzheimer's disease: recommendations Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade PET amyloid-beta imaging in preclinical Alzheimer's disease Biomarkers for cognitive impairment and dementia in elderly people.Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.A semiparametric separation curve approach for comparing correlated ROC data from multiple markers The role of biomarkers in clinical trials for Alzheimer disease Biomarkers for early detection of Alzheimer pathology.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Alzheimer Disease Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.Diagnosis and biomarkers of predementia in Alzheimer's disease.In vivo human amyloid imaging.Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment Biomarkers for cognitive impairment in Parkinson disease.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans Biological markers and Alzheimer disease: a canadian perspective Alzheimer's disease progression model based on integrated biomarkers and clinical measures.CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease Cerebrospinal fluid biomarkers for dementia with lewy bodies.General anesthetic and the risk of dementia in elderly patients: current insights.Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid

P2860

Q22252572-79BEF286-BA77-4102-96A7-0231707F7B0A Q24594531-FC7C0C8A-8289-4145-A775-2954D94635DD Q24650667-9B8CF6F5-A58E-4983-90A6-F7693A4F8BFC Q26766934-FFC0A960-5439-4184-8E1D-8CD2C2632899 Q26801666-645FEBBF-FE2C-4431-BF38-CCD30C650144 Q27009157-279210B0-12A4-467D-A70B-5958D10B4EB3 Q27027319-9777A24C-3166-4E99-948F-6B2CB51FC67B Q29614407-A16846BA-28D1-41A3-92C2-A7765CC602AF Q30040695-38A990B1-8918-4E55-8C80-429E4417CF05 Q30370745-786961AE-CD1A-4580-89AC-33F81185D11D Q30423717-6B762259-EFF7-4A37-936A-216179098759 Q30573781-C448D85F-C877-4099-8366-4982EB5EFE81 Q31032781-02074532-21C4-4D40-84FB-4CEE0451FD33 Q31140680-E538F09E-7B49-418B-A831-6A798210962E Q33237201-9B149EA2-8781-42A7-B4A3-AA39E0D0B32F Q33560183-01BA92B3-830F-4757-BAA2-4CE0ADED54A6 Q33562441-AAED75F8-30AA-41AC-9CDD-370484034552 Q33666765-92F960F9-76F4-42D2-B9D9-1A5ECC0C648D Q33687554-1CD8455F-A981-4EC0-B362-19771D07B081 Q33695738-C0EA773E-0C3D-4D98-9086-F3AA7EDC1180 Q33769278-E93C296F-1012-456A-941F-5086A17860E3 Q33777509-508AFBA8-2113-4D58-B87B-2C23D303012C Q33790277-2A935D1A-127D-4B81-B964-59C2DB172431 Q33821194-ED9BE151-F3FF-4F96-A9A0-9BFEF4FD737E Q33850134-FAE17E42-C1C2-415D-9CF7-5A69CAEC5CB7 Q33894316-6FA1687A-4CF3-430E-B0D5-10B33EE50841 Q33896664-C5C50FFF-EDC5-4A23-B183-88683F1DC324 Q33936708-FD368FF8-6D61-42D8-9D2F-F845983FB082 Q33987747-84E28158-E5EC-41B3-BE67-E18451C2BB1D Q34039952-7A6D79E4-E966-4FD8-81A4-9371B1EAA588 Q34081087-D544D46F-04AA-4A95-992C-B4D2417A5CCD Q34089784-82EBA182-59FD-402A-9FB6-C7C7ADEEFE59 Q34138353-810814DC-2700-4892-AB1A-FF2B32B1EAA1 Q34140382-E4FBD3A1-9E82-401F-8C8E-5F172AD7622A Q34247849-C0B87A37-8D7C-4299-B250-0376BC41B54A Q34248241-9A290611-B313-441A-AF15-E5B683190851 Q34273322-C7FD09F5-FF86-4C6A-BC8B-8307F7BACA8D Q34315258-6AC35F90-F6BB-42D7-9243-F9DF723B37C8 Q34637899-3A8B618C-CFB0-47B1-B4CB-BBFCFE65DA0C Q34699437-0EE3EAE9-49CD-42CC-9B83-5337CD844616

P2860

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

http://www.wikidata.org/entity/Q53259076

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@en

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@nl

type

label

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@en

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@nl

prefLabel

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@en

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@nl

P1433

Q53259076-C1404862-5230-4288-BDFD-AF9E205C9136

P1476

Q53259076-3BE0506C-85F0-405C-83BA-9028EB3169E3

P2093

Q53259076-20FFC842-A5CC-4A17-BB4F-C6A26946AC1E

Q53259076-2165AB25-3A0A-4519-B00F-7BD64C3578DA

Q53259076-28D931C4-FE50-45D7-B7B0-4932E4076B91

Q53259076-2BF6390F-A813-43D6-96B8-DF2239D5A7F8

Q53259076-2CE869EA-316F-493D-AC73-FEE4B4433EC2

Q53259076-498156C1-67BC-4EDD-BC34-2D3B3163B151

Q53259076-5216F077-15A7-4229-BFD9-2432BFDFED11

Q53259076-5A189D07-E431-48FE-BBDC-009FDBECDA36

Q53259076-600BC374-A5E4-40EF-ADC0-1EA773B123B0

Q53259076-624381A8-368B-4E86-B0F8-378C9141F859

P304

Q53259076-C36A47F4-5BB6-4407-993C-0100041E2CB5

P31

Q53259076-4457D927-2598-4CB4-8235-EA8DE5F460EA

P356

Q53259076-5EF5F5C1-A66D-4192-83D8-6B517BDDD86F

P433

Q53259076-2706C946-2CCA-4B55-9048-483DA89D459F

P478

Q53259076-C4EF0594-3909-4748-B1CC-2FAB514BB371

P50

Q53259076-785C9596-7CB3-4701-988A-780DF730EBCB

Q53259076-A06435EE-CEE5-4D56-8375-A708E13811A3

Q53259076-E8146B76-04AB-4651-8B96-7ACE21E22B44

P577

Q53259076-B1BC99AC-8F31-4E34-98BA-642490246DA3

P5875

Q53259076-43307F95-BC38-42F6-A601-2199913739BD

P698

Q53259076-5A34325A-0249-4511-826E-737316A7FAF6

P921

Q53259076-1E97EFB7-235F-402B-AFB1-4D240D5C526A

Q53259076-28147E9F-46EF-4CE2-B62F-EA52319038E0

Q53259076-E9E3EEB7-B872-45EE-8641-0444736F1F5A

P356

ARCHNEUR.60.12.1696

P1433

P1476

Cerebrospinal fluid tau and be ...... -confirmed dementia diagnoses?

@en

P2093

Charles DeCarli

http://www.w3.org/2001/XMLSchema#string

Christopher M Clark

http://www.w3.org/2001/XMLSchema#string

Daniel W McKeel

http://www.w3.org/2001/XMLSchema#string

Douglas Ewbank

http://www.w3.org/2001/XMLSchema#string

Douglas Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine Peskind

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Arai

http://www.w3.org/2001/XMLSchema#string

Jesse Chittams

http://www.w3.org/2001/XMLSchema#string

John C Morris

http://www.w3.org/2001/XMLSchema#string

John Q Trojanowski

http://www.w3.org/2001/XMLSchema#string

P304

1696-1702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.60.12.1696

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

David S Knopman

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242526116

http://www.w3.org/2001/XMLSchema#string

P698

14676043

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid